Pegylated interferon alpha 2a is an effective and well-tolerated treatment option for lymphocyte-variant hypereosinophilic syndrome
| Image |  |
|---|---|
| Description | scientific article published on 13 November 2019 |
| Author/s |
author: Luke Y C Chen |
| Publication date | November 13, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |